DTC Ad Endorsement Policy Should Be Consistent With OTC Practice – FTC
This article was originally published in The Tan Sheet
Executive Summary
Endorsements and testimonials in direct-to-consumer advertising for prescription drugs should be subject to the same standards the Federal Trade Commission applies to OTC drug ads, FTC advises in Dec. 1 comments to the agency
You may also be interested in...
DTC Advertising’s Blurred Line: Rx Spots Look A Lot Like OTC Promotions
Competition in the heartburn/GERD category between prescription and OTC drugs illustrates the increasing similarities between over-the-counter and Rx direct-to-consumer advertising
FDA Minds DTC “Reminder Ad” Increase, Seeks Better “Brief Summaries”
FDA is concerned that industry may be using "reminder ads" more frequently as a way to avoid including risk information in direct-to-consumer marketing
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC